BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 23625211)

  • 21. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes: can we stop the time bomb?
    Fisher M
    Heart; 2003 May; 89 Suppl 2(Suppl 2):ii28-30; discussion ii35-7. PubMed ID: 12695433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPAR agonists for the treatment of cardiovascular disease in patients with diabetes.
    Wilding JP
    Diabetes Obes Metab; 2012 Nov; 14(11):973-82. PubMed ID: 22443197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sugar and stroke: cerebrovascular disease and blood glucose control.
    Quinn TJ; Dawson J; Walters MR
    Cardiovasc Ther; 2011 Dec; 29(6):e31-42. PubMed ID: 20491782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical therapy for peripheral arterial disease.
    Simmons A; Steffen K; Sanders S
    Curr Opin Cardiol; 2012 Nov; 27(6):592-7. PubMed ID: 23032711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes mellitus and stroke.
    Idris I; Thomson GA; Sharma JC
    Int J Clin Pract; 2006 Jan; 60(1):48-56. PubMed ID: 16409428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies.
    Kaur R; Kaur M; Singh J
    Cardiovasc Diabetol; 2018 Aug; 17(1):121. PubMed ID: 30170601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
    Scholze J; Lilienthal W; Bramlage P
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
    Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary and optimal medical management of peripheral arterial disease.
    Tattersall MC; Johnson HM; Mason PJ
    Surg Clin North Am; 2013 Aug; 93(4):761-78, vii. PubMed ID: 23885930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries.
    Hackam DG; Tan MK; Lin PJ; Mehta PG; Jaffer S; Kates M; Oh M; Grima EA; Langer A; Goodman SG; ;
    J Vasc Surg; 2006 Oct; 44(4):776-81. PubMed ID: 16930931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus.
    Nandish S; Wyatt J; Bailon O; Smith M; Oliveros R; Chilton R
    Am J Cardiol; 2011 Aug; 108(3 Suppl):42B-51B. PubMed ID: 21802580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay.
    Niswender K
    Diabetes Obes Metab; 2010 Apr; 12(4):267-87. PubMed ID: 20380648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus.
    Piaggesi A; Vallini V; Iacopi E; Tedeschi A; Scatena A; Goretti C; Rizzo L
    Minerva Cardioangiol; 2011 Feb; 59(1):101-8. PubMed ID: 21285935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus.
    Rhee SY; Kim YS; Chon S; Oh S; Woo JT; Kim SW; Kim JW
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e11-4. PubMed ID: 20934769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 2 diabetes: one disease, multiple cardiovascular risk factors.
    Calles-Escandon J; Garcia-Rubi E; Mirza S; Mortensen A
    Coron Artery Dis; 1999; 10(1):23-30. PubMed ID: 10196684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardiovascular event in elderly patients with diabetes mellitus].
    Nomura K
    Nihon Rinsho; 2013 Nov; 71(11):1954-9. PubMed ID: 24397165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological treatment of diabetic patients with respect to prevention of macrovascular disease.
    Tkác T
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S338-42. PubMed ID: 14704865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (8) Cardiovascular disease and risk management.
    American Diabetes Association
    Diabetes Care; 2015 Jan; 38 Suppl():S49-57. PubMed ID: 25537708
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic strategies to improve control of hypertension.
    Armario P; Waeber B
    J Hypertens; 2013 Mar; 31 Suppl 1():S9-12. PubMed ID: 23389085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.